Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Colorectal Cancer · CRC · Pancreatic Ductal Adenocarcinoma · PDAC · Gastrointestinal Cancer · Metastatic Pancreatic Ductal Adenocarcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Ironwood Cancer and Research Centers, Chandler, Arizona, United States
Contact: Study coordinator (Research Department) · research@ironwoodcrc.com · 480-398-7671
Mayo Clinic Hospital, Phoenix, Arizona, United States
Study coordinator · mayocliniccancerstudies@mayo.edu · 855-776-0015
HonorHealth Research Institute, Scottsdale, Arizona, United States
Contact: Study coordinator (Andrea House) · ahouse@honorhealth.com · 480-323-1364
UC San Diego Moores Cancer Center, La Jolla, California, United States
Contact: Study coordinator (Andrea Galfo) · agalfo@health.com · 858-822-4500
Cedars-Sinai Cancer at Cedars-Sinai Medical Center, Los Angeles, California, United States
Contact: Study coordinator (Naomi Geier) · naomi.geier@cshs.org · 310-423-4693
UCLA Hematology/Oncology- Santa Monica, Los Angeles, California, United States
Contact: Study coordinator (Jenna Davis) · jldavis@mednet.ucla.edu · (310) 633-8400
University of Colorado Hospital-Anschutz Cancer Pavilion, Aurora, Colorado, United States
Contact: Study coordinator (Emily Harper) · Emily.harper@cuanschutz.edu · (303) 724-9407
Yale-New Haven Hospital-Yale Cancer Center, New Haven, Connecticut, United States
Contact: Study coordinator (Stefanie Diaz) · Stefanie.Diaz@yale.edu · 475-227-1088
Contact: Study coordinator (Kwasi Boateng) · Kwasi.Boateng@yale.edu · 203-314-7948
Mayo Clinic Cancer Center, Jacksonville, Florida, United States
Study coordinator · mayocliniccancerstudies@mayo.edu · 855-776-0015
Moffitt Cancer Center, Tampa, Florida, United States
Contact: Study coordinator (Nilufar Aliyeva) · Nilufar.Aliyeva@moffitt.org · 813.745.4436
The University of Kansas Clinical Research Center, Westwood, Kansas, United States
Study coordinator · CTNurseNav@kumc.edu · 913-945-7552
The Sidney Kimmel Comprehensive Cancer Center at John Hopkins, Baltimore, Maryland, United States
Contact: Study coordinator (Colleen Apostol) · giclinicaltrials@jhmi.edu · 410-614-3644
Contact: Study coordinator (Joann Santmyer) · giclinicaltrials@jhmi.edu · 410-614-3644
Massachusetts General Hospital, Boston, Massachusetts, United States
Contact: Study coordinator (Aparna Parikh) · Aparna.Parikh@MGH.HARVARD.EDU · (617) 724-4000
Contact: Study coordinator (Bennett Caughey) · bcaughey1@mgb.org · (617) 724-4000
Dana Farber Cancer Institute, Boston, Massachusetts, United States
Contact: Study coordinator (Charlotte Healy) · charlotte_healy@dfci.harvard.edu · 617-632-5728
Mayo Clinic, Rochester, Minnesota, United States
Study coordinator · mayocliniccancerstudies@mayo.edu · 855-776-0015
Nebraska Cancer Specialists, Omaha, Nebraska, United States
Contact: Study coordinator (Ashley Servais) · aservais@nebraskacancer.com · 4029552691
Contact: Study coordinator (Evan Roberts) · eroberts@nebraskacancer.com · 4023344773
University of Nebraska Medical Center, Omaha, Nebraska, United States
Contact: Study coordinator (Mahdi Hassan) · mhassan@unmc.edu · 402-559-1947
Contact: Study coordinator (Monica Davis) · mondavis@unmc.edu · 402-559-9466
Atlantic Health System, Morristown, New Jersey, United States
Contact: Study coordinator (Salome Geene) · salome.geene@atlantichelath.org · 973-971-6373
Contact: Study coordinator (Tracey Hilden) · tracey.hilden@atlantichealth.org · 973-971-7889
Northwell Health / RJ Zuckerberg Cancer Center, Lake Success, New York, United States
Contact: Study coordinator (Deeksha Kaura) · GITrialReferral@northwell.edu · 516-734-8906
Columbia University Medical Center, New York, New York, United States
Study coordinator · cancerclinicaltrials@cumc.columbia.edu · 212-342-5162
Memorial Sloan Kettering Cancer Center Main Campus, New York, New York, United States
Duke University Medical Center, Durham, North Carolina, United States
Contact: Study coordinator (Brooke Currier) · grayson.currier@duke.edu · (919) 681-3933
University of Cincinnati Medical Center, Cincinnati, Ohio, United States
Study coordinator · cancer@uchealth.com · 513-584-7698
Stephenson Cancer Center, Oklahoma City, Oklahoma, United States
Contact: Study coordinator (Christina Caldwell) · Christina-Caldwell@ouhsc.edu · 405-271-8001
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States
Contact: Study coordinator (Jimar Hill) · Jimar.Hill@pennmedicine.upenn.edu · 215 349 8245
SCRI Oncology Partners, Nashville, Tennessee, United States
Baylor College of Medicine, Houston, Texas, United States
Contact: Study coordinator (Henry Atencio) · Henry.VillalobosAtencio@bcm.edu · 713-798-3743
Contact: Study coordinator (Glenn Wilson) · ggwilson@bcm.edu · 713-798-3468
The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Study coordinator · GIClinicalTrials@mdanderson.org
NEXT Oncology Dallas, Irving, Texas, United States
Contact: Study coordinator (Idara Ukpong) · iukpong@nextoncology.com · 972.893.8800
Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, United States
Contact: Study coordinator (Susan Sharry) · (Susan.Sharry@hci.utah.edu) · (801) 585-3453
Virginia Cancer Specialists, Fairfax, Virginia, United States
Contact: Study coordinator (Karina Castillo) · Karina.CastilloGrady@usoncology.com · 571.350.8758
Fred Hutchinson Cancer Center, Seattle, Washington, United States
Contact: Study coordinator (Matt Sherman) · mfsherman@fredhutch.org · 206-606-6347

Study leads

Study Director
Revolution Medicines

View source on ClinicalTrials.gov Contact study team (email)